ALIZY vs ZURVY: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
ALIZY is the larger of the two ($185.09B market cap): the incumbent the market prices for continued execution (13.35x forward earnings, beta 0.67). ZURVY is the smaller challenger ($112.62B), priced similarly on forward earnings (14.50x): more room to run, but more to prove. If you believe the upside is worth bigger swings, ALIZY fits (beta 0.67). If you want the steadier ride, ZURVY fits (beta 0.27).
ALIZY vs ZURVY: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ALIZY | ZURVY | What it tells you |
|---|---|---|---|
| Market cap | $185.09B | $112.62B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 13.35 | 14.50 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 13.94 | 15.26 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.67 | 0.27 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 75% of range | 68% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.72 | 3.54 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how ALIZY and ZURVY affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ALIZY and ZURVY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ALIZY and ZURVY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Allianz SE (ALIZY) do?
Allianz SE is one of the largest insurance and asset-management groups in the world, headquartered in Munich and listed on the Frankfurt (Xetra) exchange under the symbol ALV. It runs three businesses. Property-Casualty sells motor, home, commercial and specialty cover across Europe, Australia, Latin America and Asia, plus global corporate risk through Allianz Commercial and travel and assistance through Allianz Partners. Life/Health sells savings, protection, annuity and health products, with Germany, the US (Allianz Life) and Italy among the biggest markets. Asset Management is PIMCO, the fixed-income specialist, and Allianz Global Investors, which together oversee roughly EUR 2.15 trillion of third-party money. ALIZY is the US dollar American depositary receipt that trades over the counter, with each ADR representing one tenth of an ordinary share.
What does Zurich Insurance Group AG (ZURVY) do?
Zurich Insurance Group AG is one of Europe's largest insurers, founded in 1872 and based in Zurich, with about 60,000 employees. It reports three businesses. Property and casualty (P&C) is the biggest: commercial insurance for companies of every size, including the Global Specialty lines, plus retail motor and home cover. Life sells protection and savings products, mostly in Europe, Latin America and Asia Pacific. Farmers is the odd one out. Zurich owns Farmers Group, Inc., which runs the US Farmers Exchanges for a management fee; the exchanges belong to their policyholders, so Zurich earns fee income without carrying their underwriting risk.
ALIZY vs ZURVY: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- ALIZY drivers: Property-Casualty pricing and underwriting discipline; PIMCO and the asset-management flow cycle.
- ZURVY drivers: Commercial and specialty insurance, now with Beazley; Retail P&C pricing.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Natural catastrophes are the most visible risk: a severe European storm or flood season, wildfire or hurricane losses can push the P&C combined ratio up several points in a single quarter, as the third quarter of 2026 showed when catastrophes added ~5.1 points to the loss ratio. For ZURVY, catastrophe losses are the most visible risk.
ALIZY or ZURVY: which should you pick?
If the story you believe is ALIZY's (Property-Casualty pricing and underwriting discipline), ALIZY is the more direct way to own it; if it is ZURVY's (Commercial and specialty insurance, now with Beazley), ZURVY is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ALIZY and ZURVY guides.
ALIZY vs ZURVY: the full fundamentals
ALIZY. At about USD 49.48 per ADR on November 20, 2026, Allianz is valued at roughly USD 185 billion and trades near 14 times trailing and 13 times forward earnings on Yahoo Finance figures, with a dividend yield around 4%. Those multiples sit at the upper end of where European composite insurers have traded historically. Record profit and strong capital explain the premium, though the multiples remain below many US insurers and asset managers. Allianz does not report a conventional revenue line; total business volume (premiums plus asset-management fees) is the closest equivalent, so price-to-sales comparisons with non-insurers are not meaningful.
ZURVY. Zurich reports in US dollars, pays its dividend in Swiss francs and trades in francs on SIX, so every ratio mixes currencies. At CHF 652 a share on 17 November (about US$777 at the rate implied by the ADR that day) and core earnings of about US$45 a share for 2025, the stock traded near 17 times trailing earnings and roughly 16 times an annualised first-half 2026 run rate of US$24.2; Yahoo Finance's figures for the ADR at US$37.70 on 20 November show about 15 times trailing and 14.5 times forward. Core return on equity was about 27% in 2025. The dividend yield is a gross Swiss figure, before the 35% withholding tax, and moves with the franc-dollar rate. The three analysts Yahoo Finance tracks on the ADR have a mean target near US$43.65 and a hold rating.
Headline figures (approximate, November 2026): ALIZY shows total business volume (2025) ~EUR 185bn, operating profit (2025) ~EUR 17.4bn, up ~8%, operating profit (9m 2026) ~EUR 14.1bn, up ~7.8%; Q3 ~EUR 4.7bn, up ~6.2%, core eps (9m 2026) ~EUR 24.15, up ~12.7%; ZURVY shows adr price (20 nov 2026) ~US$37.70 (1 ADR = 1/20 share), home share price (six, 17 nov 2026) ~CHF 652, market value ~US$113 billion (Yahoo Finance), business operating profit (fy2025) ~US$8.9 billion.
The bottom line: ALIZY vs ZURVY
ALIZY and ZURVY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ALIZY and ZURVY exposure against your real portfolio. It is not an investment adviser.
Wondering how ALIZY or ZURVY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Allianz SE
Ask Walnut's AI anything about ALIZY and see how it fits what you own.
FAQ
What is the difference between ALIZY and ZURVY?
+
Allianz SE is one of the largest insurance and asset-management groups in the world, headquartered in Munich and listed on the Frankfurt (Xetra) exchange under the symbol ALV. Zurich Insurance Group AG is one of Europe's largest insurers, founded in 1872 and based in Zurich, with about 60,000 employees. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ALIZY or ZURVY the better stock?
+
Neither is universally better. ALIZY is the larger incumbent; ZURVY is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ALIZY or ZURVY?
+
On forward P/E (as of November 2026), ALIZY trades at 13.35x and ZURVY at 14.50x, so ALIZY is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ALIZY and ZURVY?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ALIZY vs ZURVY?
+
ALIZY: Natural catastrophes are the most visible risk: a severe European storm or flood season, wildfire or hurricane losses can push the P&C combined ratio up several points in a single quarter, as the third quarter of 2026 showed when catastrophes added ~5.1 points to the loss ratio. The P&C pricing cycle is softening in commercial and specialty lines, which could squeeze margins after several years of rate increases. Asset Management earnings depend on bond and equity markets and on PIMCO's flows, which can reverse quickly if performance lags or rates move sharply. Allianz also carries legal and reputational history, most notably the 2022 guilty plea and roughly USD 6 billion in penalties and restitution tied to the AllianzGI Structured Alpha funds, and a related ADR-holder suit was dismissed with prejudice, a dismissal upheld on appeal in 2025. For ALIZY holders specifically, a stronger US dollar reduces the dollar value of both the share price and the euro dividend. ZURVY: Catastrophe losses are the most visible risk. Zurich's catastrophe loss ratio rose to 3.2% in the first nine months of 2026 from 1.4% a year earlier after third-quarter storms in Switzerland, Germany and Italy, and a severe US hurricane or European flood season can take a large bite out of a year's P&C profit. The commercial pricing cycle is turning: rates fell about 1% in the nine months, and a longer soft market would squeeze margins in the lines where Zurich and Beazley are biggest. Beazley brings integration risk at a large price, plus exposure to cyber and Lloyd's specialty lines that can produce volatile losses; the deal also added about US$2.9 billion of new debt and roughly 7.1 million new shares. US casualty reserves are an industry-wide concern, since lawsuit costs have pushed older claims above their reserves at several insurers. Farmers depends on the health of the Farmers Exchanges, which Zurich manages but does not own. Mario Greco has run Zurich since 2016, so succession is a live question. For US holders, the franc-dollar rate moves the ADR independently of the business, and the 35% Swiss withholding tax on dividends needs paperwork to reclaim. Sector sentiment is a further swing factor: in November 2026 Barclays turned bearish on European insurers as a group, saying their rally had outpaced earnings growth, and the three analysts Yahoo Finance tracks on the ADR have a hold consensus.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ALIZY or ZURVY; figures are approximate and dated (as of November 2026). Verify current data before investing.